Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.53 - $0.93 $312,011 - $547,491
-588,700 Reduced 48.93%
614,463 $356,000
Q4 2023

Feb 14, 2024

BUY
$0.63 - $1.14 $757,992 - $1.37 Million
1,203,163 New
1,203,163 $998,000
Q1 2023

May 15, 2023

SELL
$1.45 - $2.95 $113,390 - $230,690
-78,200 Reduced 54.16%
66,200 $100,000
Q4 2022

Feb 14, 2023

SELL
$2.02 - $3.25 $375,847 - $604,704
-186,063 Reduced 56.3%
144,400 $346,000
Q3 2022

Nov 14, 2022

BUY
$1.96 - $3.14 $201,572 - $322,927
102,843 Added 45.18%
330,463 $677,000
Q2 2022

Aug 15, 2022

SELL
$1.3 - $2.64 $502,455 - $1.02 Million
-386,504 Reduced 62.94%
227,620 $442,000
Q1 2022

May 16, 2022

SELL
$2.35 - $3.47 $227,914 - $336,537
-96,985 Reduced 13.64%
614,124 $1.51 Million
Q4 2021

Feb 14, 2022

SELL
$2.92 - $5.74 $3.46 Million - $6.8 Million
-1,184,601 Reduced 62.49%
711,109 $2.29 Million
Q3 2021

Nov 15, 2021

BUY
$4.98 - $6.63 $5.1 Million - $6.79 Million
1,023,721 Added 117.4%
1,895,710 $9.95 Million
Q2 2021

Aug 16, 2021

BUY
$2.56 - $5.49 $2.03 Million - $4.35 Million
791,465 Added 982.89%
871,989 $4.79 Million
Q1 2021

May 17, 2021

SELL
$2.69 - $5.25 $1.43 Million - $2.78 Million
-529,952 Reduced 86.81%
80,524 $219,000
Q4 2020

Feb 16, 2021

BUY
$3.17 - $4.49 $1.26 Million - $1.78 Million
397,309 Added 186.38%
610,476 $1.94 Million
Q3 2020

Nov 16, 2020

BUY
$2.98 - $5.2 $368,569 - $643,141
123,681 Added 138.21%
213,167 $853,000
Q2 2020

Aug 14, 2020

SELL
$2.29 - $4.24 $205,614 - $380,701
-89,788 Reduced 50.08%
89,486 $352,000
Q1 2020

May 15, 2020

SELL
$1.92 - $4.39 $1.61 Million - $3.67 Million
-837,109 Reduced 82.36%
179,274 $439,000
Q4 2019

Feb 14, 2020

BUY
$2.41 - $4.4 $1.05 Million - $1.92 Million
435,442 Added 74.95%
1,016,383 $4.14 Million
Q3 2019

Nov 14, 2019

SELL
$2.17 - $3.14 $591,600 - $856,048
-272,627 Reduced 31.94%
580,941 $1.5 Million
Q2 2019

Aug 14, 2019

BUY
$2.53 - $3.04 $1.03 Million - $1.24 Million
407,696 Added 91.44%
853,568 $2.56 Million
Q1 2019

May 15, 2019

BUY
$2.51 - $3.73 $405,982 - $603,312
161,746 Added 56.93%
445,872 $1.32 Million
Q4 2018

Feb 14, 2019

BUY
$1.59 - $2.66 $190,408 - $318,545
119,754 Added 72.86%
284,126 $676,000
Q3 2018

Nov 14, 2018

SELL
$1.59 - $2.42 $437,568 - $665,984
-275,200 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$2.26 - $4.65 $621,951 - $1.28 Million
275,200 New
275,200 $625,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.